Study to Investigate the Safety and Activity of Aldoxorubicin Plus Gemcitabine in Subjects With Metastatic Solid Tumors

NCT02235688 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Solid Tumors

Interventions

DRUG: aldoxorubicin
DRUG: aldoxorubicin
DRUG: aldoxorubicin
DRUG: gemcitabine

Sponsor

ImmunityBio, Inc.